Jinseob Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jinseob Kim has a total of 146 co-authors. Here are the top co-authors by number of shared publications:
- Eunseo Jo
Zarathu, Seoul, Korea
4 shared publications - Hyungjin Kim
Department of Radiology, Seoul National University Hospital and College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
4 shared publications - Jin Mo Goo
Department of Radiology, Seoul National University Hospital and Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
3 shared publications Mingu Jee
3 shared publications- Seung In Seo
Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
3 shared publications Sungho Choi
3 shared publications
Latest Publications
- 1 April 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 8 (2) , e250376
Prognostic Interaction between Emphysema and Interstitial Lung Abnormalities for Mortality in a Korean National Lung Cancer Screening Cohort
In a Korean national lung cancer screening cohort, interstitial lung abnormalities attenuated the prognostic impact of emphysema on mortality and were the dominant determinant of mortality when the conditions co-occurred.
- 1 April 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 8 (2) , e250376
Prognostic Interaction between Emphysema and Interstitial Lung Abnormalities for Mortality in a Korean National Lung Cancer Screening Cohort
In a Korean national lung cancer screening cohort, interstitial lung abnormalities attenuated the prognostic impact of emphysema on mortality and were the dominant determinant of mortality when the conditions co-occurred.
- 23 January 2026
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 23 (4) , 621-628
Additive lung cancer risk in combined interstitial lung abnormalities and emphysema: Korean national lung cancer screening program
Rationale: Interstitial lung abnormalities (ILAs) and emphysema are frequently detected during lung cancer screening (LCS), but the impact of their coexistence—termed combined ILA and emphysema (CILAE)—on lung cancer risk remains unclear. Objectives: To determine the prevalence of CILAE in a national LCS cohort, evaluate whether its effect on lung cancer risk is additive or multiplicative, and quantify its association with lung cancer incidence. Methods: This retrospective cohort study analyzed data from the Korean national LCS program (2019-2020). Participants were categorized into 4 CT-defined groups: neither condition, emphysema alone, ILA alone, and CILAE. Lung cancer incidence rate ratios (IRRs) were calculated using the neither condition group as the reference. Cox proportional hazards regression, adjusted for demographic and clinical factors, assessed the interaction and risk associated with CILAE. Results: Among 125 600 participants, CILAE was present in 1.0% (1223/125 600), ILA alone in 1.7% (2101/125 600), and emphysema alone in 12.8% (16 077/125 600). Over a median follow-up of 2.8 years (95% confidence interval [CI], 2.8-2.9 years), lung cancer was diagnosed in 1.4% (1709/125 600). Compared to neither condition, IRRs for lung cancer were 9.12 (95% CI, 7.39-11.0) for CILAE, 4.51 (95% CI, 3.63-5.44) for ILA alone, and 2.93 (95% CI, 2.66-3.20) for emphysema alone. Adjusted hazard ratios [HRs] for lung cancer were 5.17 (95% CI, 4.21-6.35; P < .001) for CILAE, 3.10 (95% CI, 2.50-3.84; P < .001) for ILA alone, and 2.05 (95% CI, 1.83-2.30; P < .001) for emphysema alone. The interaction term between ILA and emphysema was not significant (adjusted HR, 0.81 [95% CI, 0.60-1.10]; P = .17), suggesting an additive rather than multiplicative effect. Conclusions: CILAE was present in 1% of LCS participants and was associated with a lung cancer risk exceeding that of ILA or emphysema alone. The combined effect was additive rather than synergistic.
- 23 January 2026
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 23 (4) , 621-628
Additive lung cancer risk in combined interstitial lung abnormalities and emphysema: Korean national lung cancer screening program
Rationale: Interstitial lung abnormalities (ILAs) and emphysema are frequently detected during lung cancer screening (LCS), but the impact of their coexistence—termed combined ILA and emphysema (CILAE)—on lung cancer risk remains unclear. Objectives: To determine the prevalence of CILAE in a national LCS cohort, evaluate whether its effect on lung cancer risk is additive or multiplicative, and quantify its association with lung cancer incidence. Methods: This retrospective cohort study analyzed data from the Korean national LCS program (2019-2020). Participants were categorized into 4 CT-defined groups: neither condition, emphysema alone, ILA alone, and CILAE. Lung cancer incidence rate ratios (IRRs) were calculated using the neither condition group as the reference. Cox proportional hazards regression, adjusted for demographic and clinical factors, assessed the interaction and risk associated with CILAE. Results: Among 125 600 participants, CILAE was present in 1.0% (1223/125 600), ILA alone in 1.7% (2101/125 600), and emphysema alone in 12.8% (16 077/125 600). Over a median follow-up of 2.8 years (95% confidence interval [CI], 2.8-2.9 years), lung cancer was diagnosed in 1.4% (1709/125 600). Compared to neither condition, IRRs for lung cancer were 9.12 (95% CI, 7.39-11.0) for CILAE, 4.51 (95% CI, 3.63-5.44) for ILA alone, and 2.93 (95% CI, 2.66-3.20) for emphysema alone. Adjusted hazard ratios [HRs] for lung cancer were 5.17 (95% CI, 4.21-6.35; P < .001) for CILAE, 3.10 (95% CI, 2.50-3.84; P < .001) for ILA alone, and 2.05 (95% CI, 1.83-2.30; P < .001) for emphysema alone. The interaction term between ILA and emphysema was not significant (adjusted HR, 0.81 [95% CI, 0.60-1.10]; P = .17), suggesting an additive rather than multiplicative effect. Conclusions: CILAE was present in 1% of LCS participants and was associated with a lung cancer risk exceeding that of ILA or emphysema alone. The combined effect was additive rather than synergistic.
- Open Access
- 1 January 2026
- Published by XMLink in Infection & Chemotherapy
- Vol. 58 (3) , 343
Clinical Characteristics of Respiratory Syncytial Virus Infection in Korean Children: An 11-Year Multicenter Retrospective Study
Lee YH, et al. Infect Chemother. 2026 ;58:e38. https://doi.org/10.3947/ic.2026.0023
- 1 January 2026
- Published by XMLink in Infection & Chemotherapy
- Vol. 58 (3) , 343
Open AccessClinical Characteristics of Respiratory Syncytial Virus Infection in Korean Children: An 11-Year Multicenter Retrospective Study
Lee YH, et al. Infect Chemother. 2026 ;58:e38. https://doi.org/10.3947/ic.2026.0023
- 1 January 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (1) , e251656
Prevalence, Co-occurrence, and Prognostic Implications of S Modifiers in the Korean National Lung Cancer Screening Program
In a nationwide lung cancer screening cohort, structured reporting using seven standardized S modifiers revealed their prevalence and associations with all-cause mortality, validating their clinical utility in identifying clinically significant abnormalities.
- 1 January 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (1) , e251656
Prevalence, Co-occurrence, and Prognostic Implications of S Modifiers in the Korean National Lung Cancer Screening Program
In a nationwide lung cancer screening cohort, structured reporting using seven standardized S modifiers revealed their prevalence and associations with all-cause mortality, validating their clinical utility in identifying clinically significant abnormalities.
- 30 September 2025
- Published by The R Foundation
splineplot: Visualization of Spline Effects in GAM and GLM Models
Creates 'ggplot2'-based visualizations of smooth effects from GAM (Generalized Additive Models) fitted with 'mgcv' and spline effects from GLM (Generalized Linear Models). Supports interaction terms and provides hazard ratio plots with histograms for survival analysis. Wood (2017, ISBN:9781498728331) provides comprehensive methodology for generalized additive models.
- 30 September 2025
- Published by The R Foundation
splineplot: Visualization of Spline Effects in GAM and GLM Models
Creates 'ggplot2'-based visualizations of smooth effects from GAM (Generalized Additive Models) fitted with 'mgcv' and spline effects from GLM (Generalized Linear Models). Supports interaction terms and provides hazard ratio plots with histograms for survival analysis. Wood (2017, ISBN:9781498728331) provides comprehensive methodology for generalized additive models.
- 28 September 2025
- Published by Elsevier in Pancreatology
- Vol. 25 (7) , 1046-1054
Prognostic impact of serum triglycerides in acute pancreatitis: Evidence from multi-center cohort study using a common data model
- 28 September 2025
- Published by Elsevier in Pancreatology
- Vol. 25 (7) , 1046-1054
Prognostic impact of serum triglycerides in acute pancreatitis: Evidence from multi-center cohort study using a common data model
- 22 January 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 110 (10) , e3401-e3409
The Role of the Parametric Thyroid Feedback Quantile Index in Cardiovascular Risk Evaluation Among Euthyroid Koreans
Context: Thyroid hormones play a crucial role in metabolic regulation and maintaining cardiovascular homeostasis. The Parametric Thyroid Feedback Quantile-based Index (PTFQI) assesses central thyroid hormone sensitivity by standardizing the inverse relationship between free thyroxine (T4) and TSH. Objective: To investigate the relationship between PTFQI and cardiovascular risk in the euthyroid Korean population. Methods: Using data from the 2013 through 2015 Korea National Health and Nutrition Examination Survey, we included 5160 euthyroid adults aged 18 to 80 years who were not previously diagnosed with cardiovascular or thyroid disease. Cardiovascular risk was evaluated using the Predicting Risk of Cardiovascular Disease EVENTs and pooled cohort equations scores. Results: Stratification by PTFQI quartiles revealed an inverse relationship between PTFQI and cardiovascular risk. Higher PTFQI quartiles were associated with lower risks of cardiovascular disease (adjusted odds ratio [aOR], -0.55; 95% CI, -.92 to -.18), atherosclerotic cardiovascular disease (aOR, -0.31; 95% CI, -.53 to -.08), heart failure (aOR, -0.26; 95% CI, -.47 to -.05), coronary heart disease (aOR, -0.15; 95% CI, –.28 to -.02), and ischemic stroke (aOR, -0.18; 95% CI, -.30 to -.06). These associations persisted after adjusting for thyroid peroxidase antibodies, iodine intake, alcohol consumption, physical activity, and income level. The pooled cohort equations score demonstrated a strong correlation with the Predicting Risk of cardiovascular disease EVENTs score. Conclusion: The PTFQI inversely correlated with cardiovascular risk among euthyroid Koreans, indicating that reduced central sensitivity to thyroid hormone is associated with lower cardiovascular risk. These results underscore the importance of considering population-specific thyroid function parameters in cardiovascular risk assessment.
- 22 January 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 110 (10) , e3401-e3409
The Role of the Parametric Thyroid Feedback Quantile Index in Cardiovascular Risk Evaluation Among Euthyroid Koreans
Context: Thyroid hormones play a crucial role in metabolic regulation and maintaining cardiovascular homeostasis. The Parametric Thyroid Feedback Quantile-based Index (PTFQI) assesses central thyroid hormone sensitivity by standardizing the inverse relationship between free thyroxine (T4) and TSH. Objective: To investigate the relationship between PTFQI and cardiovascular risk in the euthyroid Korean population. Methods: Using data from the 2013 through 2015 Korea National Health and Nutrition Examination Survey, we included 5160 euthyroid adults aged 18 to 80 years who were not previously diagnosed with cardiovascular or thyroid disease. Cardiovascular risk was evaluated using the Predicting Risk of Cardiovascular Disease EVENTs and pooled cohort equations scores. Results: Stratification by PTFQI quartiles revealed an inverse relationship between PTFQI and cardiovascular risk. Higher PTFQI quartiles were associated with lower risks of cardiovascular disease (adjusted odds ratio [aOR], -0.55; 95% CI, -.92 to -.18), atherosclerotic cardiovascular disease (aOR, -0.31; 95% CI, -.53 to -.08), heart failure (aOR, -0.26; 95% CI, -.47 to -.05), coronary heart disease (aOR, -0.15; 95% CI, –.28 to -.02), and ischemic stroke (aOR, -0.18; 95% CI, -.30 to -.06). These associations persisted after adjusting for thyroid peroxidase antibodies, iodine intake, alcohol consumption, physical activity, and income level. The pooled cohort equations score demonstrated a strong correlation with the Predicting Risk of cardiovascular disease EVENTs score. Conclusion: The PTFQI inversely correlated with cardiovascular risk among euthyroid Koreans, indicating that reduced central sensitivity to thyroid hormone is associated with lower cardiovascular risk. These results underscore the importance of considering population-specific thyroid function parameters in cardiovascular risk assessment.
- Open Access
- 1 April 2024
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 10 (1) , e47422
Timely Pulmonary Tuberculosis Diagnosis Based on the Epidemiological Disease Spectrum: Population-Based Prospective Cohort Study in the Republic of Korea
Background: Timely pulmonary tuberculosis (PTB) diagnosis is a global health priority for interrupting transmission and optimizing treatment outcomes. The traditional dichotomous time-divided approach for addressing time delays in diagnosis has limited clinical application because the time delay significantly varies depending on each community in question. Objective: We aimed to reevaluate the diagnosis time delay based on the PTB disease spectrum using a novel scoring system that was applied at the national level in the Republic of Korea. Methods: The Pulmonary Tuberculosis Spectrum Score (PTBSS) was developed based on previously published proposals related to the disease spectrum, and its validity was assessed by examining both all-cause and PTB-related mortality. In our analysis, we integrated the PTBSS into the Korea Tuberculosis Cohort Registry. We evaluated various time delays, including patient, health care, and overall delays, and their system-associated variables in line with each PTBSS. Furthermore, we reclassified the scores into distinct categories of mild (PTBSS=0-1), moderate (PBTBSS=2-3), and severe (PBTBSS=4-6) using a multivariate regression approach. Results: Among the 14,031 Korean patients with active PTB whose data were analyzed from 2018 to 2020, 37% (n=5191), 38% (n=5328), and 25% (n=3512) were classified as having a mild, moderate, and severe disease status, respectively, according to the PTBSS. This classification can therefore reflect the disease spectrum of PTB by considering the correlation of the score with mortality. The time delay patterns differed according to the PTBSS. In health care delays according to the PTBSS, greater PTB disease progression was associated with a shorter diagnosis period, since the condition is microbiologically easy to diagnose. However, with respect to patient delays, the change in elapsed time showed a U-shaped pattern as PTB progressed. This means that a remarkable patient delay in the real-world setting might occur at both apical ends of the spectrum (ie, in both mild and severe cases of PTB). Independent risk factors for a severe PTB pattern were age (adjusted odds ratio 1.014) and male sex (adjusted odds ratio 1.422), whereas no significant risk factor was found for mild PTB. Conclusions: Timely PTB diagnosis should be accomplished. This can be improved with use of the PTBSS, a simple and intuitive scoring system, which can be more helpful in clinical and public health applications compared to the traditional dichotomous time-only approach.
- 1 April 2024
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 10 (1) , e47422
Open AccessTimely Pulmonary Tuberculosis Diagnosis Based on the Epidemiological Disease Spectrum: Population-Based Prospective Cohort Study in the Republic of Korea
Background: Timely pulmonary tuberculosis (PTB) diagnosis is a global health priority for interrupting transmission and optimizing treatment outcomes. The traditional dichotomous time-divided approach for addressing time delays in diagnosis has limited clinical application because the time delay significantly varies depending on each community in question. Objective: We aimed to reevaluate the diagnosis time delay based on the PTB disease spectrum using a novel scoring system that was applied at the national level in the Republic of Korea. Methods: The Pulmonary Tuberculosis Spectrum Score (PTBSS) was developed based on previously published proposals related to the disease spectrum, and its validity was assessed by examining both all-cause and PTB-related mortality. In our analysis, we integrated the PTBSS into the Korea Tuberculosis Cohort Registry. We evaluated various time delays, including patient, health care, and overall delays, and their system-associated variables in line with each PTBSS. Furthermore, we reclassified the scores into distinct categories of mild (PTBSS=0-1), moderate (PBTBSS=2-3), and severe (PBTBSS=4-6) using a multivariate regression approach. Results: Among the 14,031 Korean patients with active PTB whose data were analyzed from 2018 to 2020, 37% (n=5191), 38% (n=5328), and 25% (n=3512) were classified as having a mild, moderate, and severe disease status, respectively, according to the PTBSS. This classification can therefore reflect the disease spectrum of PTB by considering the correlation of the score with mortality. The time delay patterns differed according to the PTBSS. In health care delays according to the PTBSS, greater PTB disease progression was associated with a shorter diagnosis period, since the condition is microbiologically easy to diagnose. However, with respect to patient delays, the change in elapsed time showed a U-shaped pattern as PTB progressed. This means that a remarkable patient delay in the real-world setting might occur at both apical ends of the spectrum (ie, in both mild and severe cases of PTB). Independent risk factors for a severe PTB pattern were age (adjusted odds ratio 1.014) and male sex (adjusted odds ratio 1.422), whereas no significant risk factor was found for mild PTB. Conclusions: Timely PTB diagnosis should be accomplished. This can be improved with use of the PTBSS, a simple and intuitive scoring system, which can be more helpful in clinical and public health applications compared to the traditional dichotomous time-only approach.
- Open Access
- 15 August 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (16) , e029484
Cardiovascular Outcomes of Coronary Computed Tomography Angiography Versus Functional Testing in Suspected Coronary Syndromes: Real‐World Evidence From the Nationwide Cohort
Background: Real‐world evidence for the selection of gatekeeping studies in patients with suspected coronary syndromes is limited. Methods and Results: We identified 27 036 patients who underwent coronary computed tomography angiography (CCTA), single‐photon emission computed tomography, and the treadmill test for suspected coronary syndromes from the Korean National Health Insurance Service–National Sample Cohort between 2006 and 2014. The primary end point was a composite of cardiac death and myocardial infarction, and the secondary end point was a composite of the primary end point and revascularization. During a median follow‐up of 5.4 years, the risk of both primary and secondary end points was significantly higher in the single‐photon emission computed tomography group (hazard ratio [HR], 1.81 [95% CI, 1.34–2.45]; and HR, 1.42 [95% CI, 1.22–1.66]), but significantly lower in the treadmill test group (HR, 0.53 [95% CI, 0.42–0.67]; and HR, 0.69 [95% CI, 0.62–0.76]) compared with the CCTA group. After balancing baseline risk factors, there was no significant difference in the primary end point in those with single‐photon emission computed tomography (HR, 1.11 [95% CI, 0.78–1.57]; P =0.58) or treadmill test (HR, 0.84 [95% CI, 0.65–1.08]; P =0.18) groups, compared with the CCTA group. The event rate of the secondary end point was significantly lower in the treadmill test group than in the CCTA group (HR, 0.87 [95% CI, 0.78–0.96]; P =0.008). Conclusions: Compared with functional testing, initial CCTA was not associated with a lower rate of cardiac death or myocardial infarction when used as an initial diagnostic test for patients with suspected coronary syndromes.
- 15 August 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (16) , e029484
Open AccessCardiovascular Outcomes of Coronary Computed Tomography Angiography Versus Functional Testing in Suspected Coronary Syndromes: Real‐World Evidence From the Nationwide Cohort
Background: Real‐world evidence for the selection of gatekeeping studies in patients with suspected coronary syndromes is limited. Methods and Results: We identified 27 036 patients who underwent coronary computed tomography angiography (CCTA), single‐photon emission computed tomography, and the treadmill test for suspected coronary syndromes from the Korean National Health Insurance Service–National Sample Cohort between 2006 and 2014. The primary end point was a composite of cardiac death and myocardial infarction, and the secondary end point was a composite of the primary end point and revascularization. During a median follow‐up of 5.4 years, the risk of both primary and secondary end points was significantly higher in the single‐photon emission computed tomography group (hazard ratio [HR], 1.81 [95% CI, 1.34–2.45]; and HR, 1.42 [95% CI, 1.22–1.66]), but significantly lower in the treadmill test group (HR, 0.53 [95% CI, 0.42–0.67]; and HR, 0.69 [95% CI, 0.62–0.76]) compared with the CCTA group. After balancing baseline risk factors, there was no significant difference in the primary end point in those with single‐photon emission computed tomography (HR, 1.11 [95% CI, 0.78–1.57]; P =0.58) or treadmill test (HR, 0.84 [95% CI, 0.65–1.08]; P =0.18) groups, compared with the CCTA group. The event rate of the secondary end point was significantly lower in the treadmill test group than in the CCTA group (HR, 0.87 [95% CI, 0.78–0.96]; P =0.008). Conclusions: Compared with functional testing, initial CCTA was not associated with a lower rate of cardiac death or myocardial infarction when used as an initial diagnostic test for patients with suspected coronary syndromes.